Announce Date | 08/06/2025 |
EPS Normalized Actual | $1.16 (Miss by $-0.01) |
EPS GAAP Actual | $1.16 (Miss by $-0.01) |
Revenue Actual | $0.838774B |
Revenue Surprise | Beat by $838.774M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2029 | 9.35 | 18.2 | 8.9028 | 9.88982 | 1 |
Sep 2028 | 8.55 | 19.91 | 7.95165 | 9.41193 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.1699 | 1.1699 | 0.838774B | 16.36% | 838.77M |
FQ1 2025 (Mar 2025) | 3.05 | 3.05 | 1.9505B | 15.55% | 1950.5M |
FQ4 2024 (Dec 2024) | 2.25 | 2.25 | 1.176B | 1.49% | 1176M |
FQ3 2024 (Sep 2024) | 0 | 0 | 0.657944B | 10.69% | 657.94M |
FQ2 2024 (Jun 2024) | 1.08 | 1.08 | 0.701549B | 5.53% | 701.55M |
FQ1 2024 (Mar 2024) | 2.86 | 2.86 | 1.64723B | 6.45% | 1647.23M |
FQ4 2023 (Dec 2023) | 2.08 | 2.08 | 1.15847B | -24.34% | 1158.47M |
FQ3 2023 (Sep 2023) | 0.8 | 0.8 | 0.587642B | -1.51% | 587.64M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2029 (Jun 2029) | 1.4357 | -- | 1.13918 | 1.5458 | 1 |
FQ1 2029 (Mar 2029) | 4.0425 | -- | 3.20758 | 4.35251 | 1 |
FQ4 2028 (Oct 2028) | 0.5835 | -- | 0.5835 | 0.5835 | 2 |
FQ3 2028 (Jul 2028) | 0.6974 | -- | 0.6974 | 0.6974 | 2 |
FQ2 2028 (Jun 2028) | 0.6974 | -- | 0.66369 | 0.73111 | 2 |
FQ1 2028 (Mar 2028) | 1.8751 | -- | 1.78446 | 1.96574 | 2 |
FQ4 2027 (Oct 2027) | 0.5403 | -- | 0.5403 | 0.5403 | 1 |
FQ3 2027 (Jul 2027) | 0.6457 | -- | 0.6457 | 0.6457 | 1 |
FQ2 2027 (Jun 2027) | 0.6457 | -- | 0.61449 | 0.67691 | 1 |
FQ1 2027 (Mar 2027) | 1.7361 | -- | 1.65218 | 1.82002 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2029 (Jun 2029) | 1.87B | -- | 1.57B | 1.98B | 1 |
FQ1 2029 (Mar 2029) | 1.82B | -- | 1.53B | 1.93B | 1 |
FQ4 2028 (Oct 2028) | 2.61B | -- | 2.61B | 2.61B | 0 |
FQ3 2028 (Jul 2028) | 2.54B | -- | 2.54B | 2.54B | 0 |
FQ2 2028 (Jun 2028) | 1.06B | -- | 1.02B | 1.1B | 0 |
FQ1 2028 (Mar 2028) | 1.03B | -- | 0.99B | 1.07B | 0 |
FQ4 2027 (Oct 2027) | 2.36B | -- | 2.36B | 2.36B | 1 |
FQ3 2027 (Jul 2027) | 2.3B | -- | 2.3B | 2.3B | 1 |
FQ2 2027 (Jun 2027) | 0.95B | -- | 0.92B | 0.99B | 1 |
FQ1 2027 (Mar 2027) | 0.93B | -- | 0.89B | 0.96B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.1699 | 1.1699 | 100% | |
FQ1 2025 (Mar 2025) | 3.05 | 3.05 | 100% | |
FQ4 2024 (Dec 2024) | 2.25 | 2.25 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 1.08 | 1.08 | 100% | |
FQ1 2024 (Mar 2024) | 2.86 | 2.86 | 100% | |
FQ4 2023 (Dec 2023) | 2.08 | 2.08 | 100% | |
FQ3 2023 (Sep 2023) | 0.8 | 0.8 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0.84B | $838.77M | 100% |
FQ1 2025 (Mar 2025) | $0B | $1.95B | $1950.5M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.18B | $1176M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.66B | $657.94M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.7B | $701.55M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.65B | $1647.23M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.16B | $1158.47M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.59B | $587.64M | 100% |